Functional evidence that the Ser-195 residue of staphylococcal exfoliative toxin A is essential for biological activity.

le Prévost, G, Rifai, S, Chaix, M L, Piémont, Y
Foilsithe 1991

Patient-Specific Cytotoxic T-Lymphocyte Cross-Recognition of Naturally Occurring Variants of a Human Immunodeficiency Virus Type 1 (HIV-1) p24(gag) Epitope by HIV-1-Infected Childr...

le Buseyne, F., Chaix, M.-L., Rouzioux, C., Blanche, S., Rivière, Y.
Foilsithe 2001

A10 Presence and frequency of M184V mutation in the MOBIDIP trial

le Armero, A, Chaix, M L, Nere, M L, Delaporte, E, Peeters, M, Delaugerre, C
Foilsithe in Virus Evol (2019)

Detailed analysis of the genetic evolution of influenza virus during the course of an epidemic

le LAVENU, A., LERUEZ-VILLE, M., CHAIX, M.-L., BOELLE, P.-Y., ROGEZ, S., FREYMUTH, F., HAY, A., ROUZIOUX, C., CARRAT, F.
Foilsithe 2006

Increase in hepatitis C virus incidence in HIV‐1‐infected patients followed up since primary infection

le Ghosn, J, Deveau, C, Goujard, C, Garrigue, I, Saïchi, N, Galimand, J, Nagy, Z, Rouzioux, C, Meyer, L, Chaix, M‐L
Foilsithe 2006

Variability of human immunodeficiency virus type 1 group O strains isolated from Cameroonian patients living in France.

le Loussert-Ajaka, I, Chaix, M L, Korber, B, Letourneur, F, Gomas, E, Allen, E, Ly, T D, Brun-Vézinet, F, Simon, F, Saragosti, S
Foilsithe 1995

HIV-1 subtype influences susceptibility and response to monotherapy with the protease inhibitor lopinavir/ritonavir

le Sutherland, K. A., Ghosn, J., Gregson, J., Mbisa, J. L., Chaix, M. L., Cohen Codar, I., Delfraissy, J. F., Delaugerre, C., Gupta, R. K.
Foilsithe in J Antimicrob Chemother (2015)

Evaluation of an Upgraded Version of the Roche Cobas AmpliPrep/Cobas TaqMan HIV-1 Test for HIV-1 Load Quantification

le Damond, F., Avettand-Fenoel, V., Collin, G., Roquebert, B., Plantier, J. C., Ganon, A., Sizmann, D., Babiel, R., Glaubitz, J., Chaix, M. L., Brun-Vezinet, F., Descamps, D., Rouzioux, C.
Foilsithe 2010